Boston Children's Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

    The Lancet, Vol. 396, Núm. 10267, pp. 1979-1993